These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
111 related items for PubMed ID: 429131
1. The Nb rat: prostatic adenocarcinoma model. Drago JR, Ikeda RM, Maurer RE, Goldman LB, Tesluk H. Invest Urol; 1979 Mar; 16(5):353-9. PubMed ID: 429131 [Abstract] [Full Text] [Related]
2. The Nb rat prostatic adenocarcinoma model system. Drago JR, Goldman LB, Maurer RE. Prog Clin Biol Res; 1980 Mar; 37():265-91. PubMed ID: 7384086 [Abstract] [Full Text] [Related]
3. Prostate carcinoma of the Nb rat in relation to hormones. Noble RL. Int Rev Exp Pathol; 1982 Mar; 23():113-59. PubMed ID: 7045013 [No Abstract] [Full Text] [Related]
7. Chemotherapeutic and hormonal considerations of the Nb rat prostatic adenocarcinoma model. Drago JR, Goldman LB, Gershwin ME. Prog Clin Biol Res; 1980 Mar; 37():325-63. PubMed ID: 7384092 [No Abstract] [Full Text] [Related]
8. Characterization of the Dunning R3327H prostatic adenocarcinoma: an appropriate animal model for prostatic cancer. Smolev JK, Heston WD, Scott WW, Coffey DS. Cancer Treat Rep; 1977 Mar; 61(2):273-87. PubMed ID: 872132 [Abstract] [Full Text] [Related]
9. Cell cycle-independent death of prostate adenocarcinoma is induced by the trk tyrosine kinase inhibitor CEP-751 (KT6587). Dionne CA, Camoratto AM, Jani JP, Emerson E, Neff N, Vaught JL, Murakata C, Djakiew D, Lamb J, Bova S, George D, Isaacs JT. Clin Cancer Res; 1998 Aug; 4(8):1887-98. PubMed ID: 9717816 [Abstract] [Full Text] [Related]
12. The evaluation of heparin in control of metastasis of Nb rat androgen-insensitive prostate carcinoma. Drago JR, Weed P, Fralisch A. Anticancer Res; 1984 Aug; 4(3):171-2. PubMed ID: 6540544 [Abstract] [Full Text] [Related]
13. Animal model of human disease: metastic adenocarcinoma of the prostate. Pollard M. Am J Pathol; 1977 Jan; 86(1):277-80. PubMed ID: 831516 [No Abstract] [Full Text] [Related]
14. An animal model for the study of prostate carcinoma. Lubaroff DM, Canfield L, Rasmussen GT, Reynolds CW. Natl Cancer Inst Monogr; 1978 Dec; (49):275-81. PubMed ID: 748781 [Abstract] [Full Text] [Related]
15. Molecular cloning and functional study of rat estrogen receptor-related receptor gamma in rat prostatic cells. Lui K, Huang Y, Choi HL, Yu S, Wong KB, Chen S, Chan FL. Prostate; 2006 Nov 01; 66(15):1600-19. PubMed ID: 16927302 [Abstract] [Full Text] [Related]
16. Therapeutic manipulation of Nb rat prostatic adenocarcinomas: chemotherapeutic evaluation of autonomous tumors. Drago JR, Goldman LB, Maurer RE, Gershwin ME, Eckels DD. Invest Urol; 1979 Nov 01; 17(3):203-6. PubMed ID: 500317 [Abstract] [Full Text] [Related]
17. Immunobiology and therapeutic manipulation of heterotransplanted Nb rat prostate adenocarcinoma into congenitally athymic (nude) mice. I. Hormone dependency and histopathology. Drago JR, Gershwin ME, Maurer RE, Ikeda RM, Eckels DD. J Natl Cancer Inst; 1979 Apr 01; 62(4):1057-66. PubMed ID: 285279 [No Abstract] [Full Text] [Related]
18. A rat prostatic adenocarcinoma as a model for the human disease. Müntzing J, Kirdani RY, Murphy GP, Sandberg AA. Invest Urol; 1979 Jul 01; 17(1):37-41. PubMed ID: 447485 [Abstract] [Full Text] [Related]
19. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential. Masumori N, Thomas TZ, Chaurand P, Case T, Paul M, Kasper S, Caprioli RM, Tsukamoto T, Shappell SB, Matusik RJ. Cancer Res; 2001 Mar 01; 61(5):2239-49. PubMed ID: 11280793 [Abstract] [Full Text] [Related]
20. An animal model for the study of prostatic adenocarcinoma. Fingerhut B, Veenema RJ. Invest Urol; 1977 Jul 01; 15(1):42-8. PubMed ID: 406218 [Abstract] [Full Text] [Related] Page: [Next] [New Search]